Harrow Health (HROW) Misses Q3 EPS by 15c, Misses on Revenue; Offers FY23 Revenue Guidance

Harrow Health (NASDAQ: HROW) reported Q3 EPS of ($0.09), $0.15 worse than the analyst estimate of $0.06. Revenue for the quarter came in at $34.3 million versus the consensus estimate of $37.69 million.

GUIDANCE:

Harrow Health sees FY2023 revenue of $129-136 million, versus the consensus of $141.5 million.

For earnings history and earnings-related data on Harrow Health (HROW) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c
• Reading (RDI) Tops Q2 EPS by 4c